Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gregoire Ruffenach

Has grant

Researcher

INSERM

France

Research Interests

Explore related searches

Professors in France

Recent Grants

Grant: Open

Role of Transcription Factor TBX4 in Pulmonary Arterial Hypertension

Open Date: 2026-01-01

Close Date: 2030-01-01

Grant: Close

ZFP36, an RNA Binding Protein that Regulates DNA Repair and Cell Proliferation in PAH

Open Date: 2024-07-01

Close Date: 2024-11-01

Grant: Close

Role of a novel RNA-binding protein in promoting pulmonary hypertension induced by oxidized lipids

Open Date: 2020-08-01

Close Date: 2023-07-31

Grant: Close

Therapeutic role of miR193 in Pulmonary Arterial Hypertension

Open Date:

Close Date: 2019-07-01

Articles (15)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

David Montani

Professeur des Universités - Praticien Hospitalier

Université de Paris Faculté de Santé

FRANCE

View details

Carmen Bras Silva

Assistant Professor

Faculty of Medicine of the University of Porto

PORTUGAL

View details

Christopher Rhodes

Imperial College London

UNITED KINGDOM

View details

Frédéric Perros

Director of research

FRANCE

View details

INSERM

FRANCE

View details

Marco Mura

Associate Professor of Medicine

Western University

CANADA

View details

Zeyneb Kurt

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregoire Ruffenach

Research Interests

Explore related searches

Recent Grants

Articles (15)

Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertension

Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary Hypertension.

SOX17 in pulmonary arterial hypertension: from development to clinical phenotype

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

Ca 2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction

TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension.

Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension.

Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction.

Dissecting the lung transcriptome of pulmonary fibrosis-associated pulmonary hypertension

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertension.

Transcriptome analyses reveal common immune system dysregulation in PAH patients and Kcnk3‐deficient rats

Functions of RNA-Binding Proteins in Cardiovascular Disease

Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts.

Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension.

Collaborators (12)

David Montani

Carmen Bras Silva

Christopher Rhodes

Frédéric Perros

Laurent Savale

Olaf Mercier

Bastien Masson

Marc Humbert

Steeve Provencher

Fabrice Antigny

Marco Mura

Zeyneb Kurt

Make your next move.

Gregoire Ruffenach

Research Interests

Explore related searches

Recent Grants

Articles (15)

Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial hypertension

Breast Cancer Reveals Latent &lt;i&gt;BMPR2&lt;/i&gt;-Related Susceptibility to Pulmonary Hypertension.

SOX17 in pulmonary arterial hypertension: from development to clinical phenotype

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

Ca 2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction

TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension.

Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension.

Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction.

Dissecting the lung transcriptome of pulmonary fibrosis-associated pulmonary hypertension

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension

Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertension.

Transcriptome analyses reveal common immune system dysregulation in PAH patients and Kcnk3‐deficient rats

Functions of RNA-Binding Proteins in Cardiovascular Disease

Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts.

Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension.

Collaborators (12)

David Montani

Carmen Bras Silva

Christopher Rhodes

Frédéric Perros

Laurent Savale

Olaf Mercier

Bastien Masson

Marc Humbert

Steeve Provencher

Fabrice Antigny

Marco Mura

Zeyneb Kurt

Make your next move.

Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary Hypertension.